GPGI Stock Analysis: GPGI | NYSE
Metal Fabrication | NYSE, USA | Market Cap: 4.855m USD | 12M Return: 1.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.0M
EPS Trend: 37.2%
Qual. Beats: 1
Rev. Trend: -84.9%
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GPGI, Inc. is a U.S.-based industrial company that operates two main businesses: its CompoSecure unit, which produces metal payment cards and security/authentication solutions, and an engineered injection molding segment that supplies precision equipment, tooling, and aftermarket services for industries including food, beverages, medical devices, packaging, closures, and consumer products. The company was founded in 2000, is headquartered in Somerset, New Jersey, and rebranded from CompoSecure, Inc. to GPGI, Inc. in January 2026. It trades on the NYSE under the ticker GPGI and is classified within the Industrials sector and Metal Fabrication industry.
Sector and business model context: The metal payment card market is a niche premium segment of the global card industry, typically serving high-end credit, debit, and prepaid card programs where issuers use metal construction as a differentiating feature. The injection molding side of the business is capital-equipment intensive, generating revenue both from initial machinery sales and from recurring aftermarket tooling, parts, and service contracts-a model that typically provides more stable cash flow than equipment sales alone.
- Premium metal payment card demand drives CompoSecure segment growth
- Injection molding equipment sales expand across food and medical packaging markets
- Raw material cost inflation pressures metal card and equipment margins
| Net Income: -392.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -33.25 > 1.0 |
| NWC/Revenue: -3.34% < 20% (prev -9.64%; Δ 6.29% < -1%) |
| CFO/TA -0.02 > 3% & CFO -78.5m > Net Income -392.5m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (289.7m) vs 12m ago 155.7% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 3.23% > 50% (prev 128.8%; Δ -125.5% > 0%) |
| Interest Coverage Ratio: -44.65 > 6 (EBIT TTM -75.4m / Interest Expense TTM 1.69m) |
| A: -0.00 (Total Current Assets 22.9m - Total Current Liabilities 24.9m) / Total Assets 3.41b |
| B: -0.20 (Retained Earnings -686.8m / Total Assets 3.41b) |
| C: -0.04 (EBIT TTM -75.4m / Avg Total Assets 1.85b) |
| D: 10.46 (Book Value of Equity 3.12b / Total Liabilities 297.8m) |
| Altman-Z'' = 10.05 = AAA |
As of July 13, 2026, the stock is trading at USD 14.59 with a total of 1,105,087 shares traded. Over the past week, the price has changed by -12.90%, over one month by +13.98%, over three months by -10.96% and over the past year by +1.71%.
Current recommended Stop Loss: 13.40 (which is 8.2% or 1.3 ATR below the current price).
GPGI has no consensus analysts rating.
P/E Forward = 20.1613
P/S = 202299.14
P/B = 1.558
Revenue TTM = 59.8m USD
EBIT TTM = -75.4m USD
EBITDA TTM = -75.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.85b USD (4.86b + (null Debt) - CCE 6.50m)
Interest Coverage Ratio = -44.65 (Ebit TTM -75.4m / Interest Expense TTM 1.69m)
EV/FCF = -62.09x (Enterprise Value 4.85b / FCF TTM -78.1m)
FCF Yield = -1.61% (FCF TTM -78.1m / Enterprise Value 4.85b)
FCF Margin = -130.5% (FCF TTM -78.1m / Revenue TTM 59.8m)
Net Margin = -656.1% (Net Income TTM -392.5m / Revenue TTM 59.8m)
Gross Margin = unknown ((Revenue TTM 59.8m - Cost of Revenue TTM 2.00k) / Revenue TTM)
Tobins Q-Ratio = 1.42 (Enterprise Value 4.85b / Total Assets 3.41b)
Interest Expense / Debt = unknown (Interest Expense 1.69m / Debt none)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -59.5m (EBIT -75.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.92 (Total Current Assets 22.9m / Total Current Liabilities 24.9m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA -75.4m)
Debt / FCF = unknown (Net Debt none / FCF TTM -78.1m)
Total Stockholder Equity = 851.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.18% (Net Income -392.5m / Total Assets 3.41b)
RoE = -46.10% (Net Income TTM -392.5m / Total Stockholder Equity 851.4m)
RoCE = -2.22% (EBIT -75.4m / Capital Employed (Total Assets 3.41b - Current Liab 24.9m))
RoIC = -1.76% (negative operating profit) (NOPAT -59.5m / Invested Capital 3.39b)
WACC = 12.87% (E(4.86b)/V(4.86b) * Re(12.87%) + (debt-free company))
Discount Rate = 12.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.33 | Cagr: 232.7%
[DCF] Fair Price = unknown (Cash Flow -78.1m)
EPS Correlation: 37.24 | EPS CAGR: 2.47% | SUE: 1.21 | # QB: 1
Revenue Correlation: -84.88 | Revenue CAGR: -60.87% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.14 | Chg30d=-43.73% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.23 | Chg30d=-18.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=0.95 | Chg30d=-0.10% | Revisions=+25% | GrowthEPS=-3.9% | GrowthRev=+349.6%
EPS next Year (2027-12-31): EPS=1.28 | Chg30d=+10.60% | Revisions=+25% | GrowthEPS=+34.4% | GrowthRev=+11.0%
[Analyst] Revisions Ratio: +40% (up=2, down=0)